NASDAQ:UTHR

United Therapeutics Stock News

etoro logo Buy UTHR
*Your capital is at risk
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) Director Tommy Thompson sold 910 shares of the stock in a transaction that occurred on Thursday, December 18th. The stock was sold at a
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the company's stock in a transaction on Monday, December 15th. The shares were sold at an av
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 3,517 shares of the firm's stock in a transaction on Monday, December 15th. The shares were sold at an average
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven research firms that are presently covering the firm, MarketBeat.com r
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the firm's stock in a transaction on Friday, December 12th. The stock was sold at an average
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) reached a new 52-week high on Friday. The stock traded as high as $494.74 and last traded at $495.1590, with a volume of 203836 shares
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) EVP Paul Mahon sold 11,000 shares of United Therapeutics stock in a transaction that occurred on Thursday, December 11th. The stock was
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) COO Michael Benkowitz sold 22,500 shares of the stock in a transaction dated Monday, December 8th. The shares were sold at an average p
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 21,000 shares of United Therapeutics stock in a transaction dated Monday, December 8th. The stock was sold at a
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cresset Asset Management LLC lowered its position in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 37.3% in the second quarter, according to the company in its most recent filing with th
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
United Therapeutics Corporation (UTHR) shares up 3,603% since Big Money first bought big in 2004.
Advisors Asset Management Inc. raised its stake in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 3.1% during the undefined quarter, according to the company in its most recent filing wit
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE